The estimated Net Worth of Peter E Hornstra is at least $18.6 million dollars as of 18 August 2020. Mr. Hornstra owns over 3,337 units of Thermo Fisher Scientific stock worth over $11,835,469 and over the last 21 years he sold TMO stock worth over $6,773,713. In addition, he makes $0 as Vice President et Chief Accounting Officer at Thermo Fisher Scientific.
Peter has made over 15 trades of the Thermo Fisher Scientific stock since 2003, according to the Form 4 filled with the SEC. Most recently he exercised 3,337 units of TMO stock worth $455,501 on 18 August 2020.
The largest trade he's ever made was exercising 28,426 units of Thermo Fisher Scientific stock on 2 May 2011 worth over $1,193,039. On average, Peter trades about 1,189 units every 71 days since 2003. As of 18 August 2020 he still owns at least 19,137 units of Thermo Fisher Scientific stock.
You can see the complete history of Mr. Hornstra stock trades at the bottom of the page.
Peter E. Hornstra is no longer serves as Vice President, Chief Accounting Officer of the Company effective 3/31/2021. He was Corporate Controller from January 1996 to February 2007.
Peter Hornstra is 60, he's been the Vice President et Chief Accounting Officer of Thermo Fisher Scientific since 2007. There are 8 older and 18 younger executives at Thermo Fisher Scientific. The oldest executive at Thermo Fisher Scientific Inc. is Elaine Ullian, 71, who is the Independent Director.
Over the last 21 years, insiders at Thermo Fisher Scientific have traded over $356,502,416 worth of Thermo Fisher Scientific stock and bought 4,301 units worth $223,007 . The most active insiders traders include Thomas J Lynch, Dion J Weisler et Marc N Casper. On average, Thermo Fisher Scientific executives and independent directors trade stock every 23 days with the average trade being worth of $16,400,322. The most recent stock trade was executed by Marc N Casper on 3 September 2024, trading 20,000 units of TMO stock currently worth $4,213,600.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally.
Thermo Fisher Scientific executives and other stock owners filed with the SEC include: